World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
12190
World Ranking
4039
National Ranking
1844

Best Publications

  • Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

    Unknown

  • Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

    T.T. Shimabukuro;S.Y. Kim;T.R. Myers;P.L. Moro

  • Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

    Tom T. Shimabukuro;Michael Nguyen;David Martin;Frank DeStefano

  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

    Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  • Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

    Julia W. Gargano;Megan Wallace;Stephen C. Hadler;Gayle Langley

  • US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

    Isaac See;John R. Su;Allison Lale;Emily Jane Woo

  • Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

    Unknown

  • Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014

    Lisa A. Grohskopf;David K. Shay;Tom T. Shimabukuro;Leslie Z. Sokolow

  • First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.

    Julianne Gee;Paige Marquez;John Su;Geoffrey M. Calvert

  • Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

    Unknown

  • COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021

    Unknown

  • Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

    Unknown

  • Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.

    Hannah G. Rosenblum;Stephen C. Hadler;Danielle Moulia;Tom T. Shimabukuro

  • SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020

    Lakshmi Panagiotakopoulos;Tanya R Myers;Julianne Gee;Heather S Lipkind

  • COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.

    Anne M. Hause;Julianne Gee;James Baggs;Winston E. Abara

  • Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006

    Unknown

  • Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans

    Unknown

  • Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024

    Unknown

  • The MMR Vaccine and Autism.

    Frank DeStefano;Tom T Shimabukuro

  • Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.

    David K Shay;Tom T Shimabukuro;Frank DeStefano

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Tom T. Shimabukuro

Recently Published Articles